Sublingual Ketamine Troches & Lozenges
Sublingual ketamine made telehealth programs possible — and brought a new set of safety questions with it.
This page has been written and edited by the publisher. It has not been reviewed by a licensed clinician.
Profile
- Bioavailability: ~17–30%, hold-time dependent.
- Onset: 10–20 minutes.
- Duration: 45–60 minutes for acute effects.
- Setting: clinic, KAP office, or at-home (telehealth).
Strengths
- Lower cost per session than IV/IM.
- Accessible via telehealth in many regions.
- Self-administered after training, with virtual support.
Trade-offs
- No real-time medical monitoring during at-home use.
- Higher variability in absorbed dose.
- Take-home supply raises diversion and misuse concerns.
Publisher and editor of Ketalux, based in Chicago, Illinois. Ira is a ketamine therapy patient, not a clinician. This is editorial review, not medical review: Ira is not a licensed clinician and does not provide diagnosis or medical care. Ketalux does not accept compensation from providers in exchange for favorable editorial coverage, evidence ratings, recommendations, patient referrals, or organic provider ranking. Read the full publisher disclosure →
Educational use only. The content on this page is provided for general educational purposes and does not constitute medical advice, diagnosis, or treatment. Ketamine and related therapies carry risks and are appropriate only under qualified medical supervision. Always consult a licensed healthcare professional about your individual situation. Information may change as research evolves.